For live-cell studies, we used the following plasmids: GFP-tagged HP1β [42 (
link)]; mCherry-tagged 53BP1 (
mCherry-BP1-2 pLPC-Puro (a fragment of human 53BP1, aa 1220 - 1711; #19835, Addgene, Cambridge, Massachusetts, USA), mCherry-tagged PCNA (a generous gift from prof. Christina Cardoso, Technical University, Darmstadt, Germany),
pDEST-FRT/T0-GFP-BRCA1 (#71116, Addgene, USA), and GFP-tagged JMJD2b (termed GFP-JMJD2b-1086), (a generous gift from prof. Thomas Jenuwein and Dr. Nicholas Shukeir, Max Planck Institute of Immunobiology, Freiburg, Germany). The plasmids were introduced into
E. coli DH5α, and the DNA was isolated using the
Qiagen Plasmid Maxi Kit (#121693; QIAGEN, Bio-Consult, Praha, Czech Republic). The cells were transfected with 2-5 μg plasmid DNA using
METAFECTANE (#T020–1.0, Biontex Laboratories GmbH, München, Germany) [35 (
link)].
Svobodová Kovaříková A., Legartová S., Krejčí J, & Bartová E. (2018). H3K9me3 and H4K20me3 represent the epigenetic landscape for 53BP1 binding to DNA lesions. Aging (Albany NY), 10(10), 2585-2605.